Oral manifestation in inflammatory bowel disease: a review
KB Lankarani, GR Sivandzadeh… - World journal of …, 2013 - pmc.ncbi.nlm.nih.gov
KB Lankarani, GR Sivandzadeh, S Hassanpour
World journal of gastroenterology: WJG, 2013•pmc.ncbi.nlm.nih.govInflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis,
not only affect the intestinal tract but also have an extraintestinal involvement within the oral
cavity. These oral manifestations may assist in the diagnosis and the monitoring of disease
activity, whilst ignoring them may lead to an inaccurate diagnosis and useless and
expensive workups. Indurated tag-like lesions, cobblestoning, and mucogingivitis are the
most common specific oral findings encountered in CD cases. Aphthous stomatitis and …
not only affect the intestinal tract but also have an extraintestinal involvement within the oral
cavity. These oral manifestations may assist in the diagnosis and the monitoring of disease
activity, whilst ignoring them may lead to an inaccurate diagnosis and useless and
expensive workups. Indurated tag-like lesions, cobblestoning, and mucogingivitis are the
most common specific oral findings encountered in CD cases. Aphthous stomatitis and …
Inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis, not only affect the intestinal tract but also have an extraintestinal involvement within the oral cavity. These oral manifestations may assist in the diagnosis and the monitoring of disease activity, whilst ignoring them may lead to an inaccurate diagnosis and useless and expensive workups. Indurated tag-like lesions, cobblestoning, and mucogingivitis are the most common specific oral findings encountered in CD cases. Aphthous stomatitis and pyostomatitis vegetans are among non-specific oral manifestations of IBD. In differential diagnosis, side effects of drugs, infections, nutritional deficiencies, and other inflammatory conditions should also be considered. Treatment usually involves managing the underlying intestinal disease. In severe cases with local symptoms, topical and/or systemic steroids and immunosuppressive drugs might be used.
pmc.ncbi.nlm.nih.gov